Related references
Note: Only part of the references are listed.Can daily intake of aspirin and/or statins influence the behavior of non-muscle invasive bladder cancer? A retrospective study on a cohort of patients undergoing transurethral bladder resection
Antonio Luigi Pastore et al.
BMC CANCER (2015)
Association between aspirin use and mortality in breast cancer patients: a meta-analysis of observational studies
Shanliang Zhong et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Are metformin, statin and aspirin use still associated with overall mortality among colorectal cancer patients with diabetes if adjusted for one another?
M. M. J. Zanders et al.
BRITISH JOURNAL OF CANCER (2015)
Aspirin and nonsteroidal anti-inflammatory drugs after but not before diagnosis are associated with improved breast cancer survival: a meta-analysis
Xuan-zhang Huang et al.
CANCER CAUSES & CONTROL (2015)
Aspirin and other non-steroidal anti-inflammatory drug prescriptions and survival after the diagnosis of head and neck and oesophageal cancer
Tatiana V. Macfarlane et al.
CANCER EPIDEMIOLOGY (2015)
Aspirin, nonaspirin nonsteroidal anti-inflammatory drugs, acetaminophen and ovarian cancer survival
Christina M. Nagle et al.
CANCER EPIDEMIOLOGY (2015)
De Novo Post-Diagnosis Aspirin Use and Mortality in Women with Stage I-III Breast Cancer
Thomas I. Barron et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2015)
Aspirin Has a Protective Effect Against Adverse Outcomes in Patients with Nonvariceal Upper Gastrointestinal Bleeding
Antonios Wehbeh et al.
DIGESTIVE DISEASES AND SCIENCES (2015)
The Use of Aspirin and the Risk of Mortality in Patients with Prostate Cancer
Jonathan Assayag et al.
JOURNAL OF UROLOGY (2015)
A cohort study investigating aspirin use and survival in men with prostate cancer
E. M. Flahavan et al.
ANNALS OF ONCOLOGY (2014)
Statin and aspirin use is associated with improved outcome of FCR therapy in relapsed/refractory chronic lymphocytic leukemia
Young Kwang Chae et al.
BLOOD (2014)
Aspirin intake and breast cancer survival - a nation-wide study using prospectively recorded data in Sweden
Michelle D. Holmes et al.
BMC CANCER (2014)
Effect of aspirin and other non-steroidal anti-inflammatory drugs on prostate cancer incidence and mortality: a systematic review and meta-analysis
Yanqiong Liu et al.
BMC MEDICINE (2014)
Post-diagnostic prescriptions for low-dose aspirin and breast cancer-specific survival: a nested case-control study in a breast cancer cohort from the UK Clinical Practice Research Datalink
Liam J. Murray et al.
BREAST CANCER RESEARCH (2014)
Aspirin use and survival after the diagnosis of breast cancer: a population-based cohort study
D. M. Fraser et al.
BRITISH JOURNAL OF CANCER (2014)
Aspirin improves outcome in high risk prostate cancer patients treated with radiation therapy
Corbin D. Jacobs et al.
CANCER BIOLOGY & THERAPY (2014)
Recent Prediagnostic Aspirin Use, Lymph Node Involvement, and 5-Year Mortality in Women with Stage I-III Breast Cancer: A Nationwide Population-Based Cohort Study
Thomas I. Barron et al.
CANCER RESEARCH (2014)
NSAID Use Reduces Breast Cancer Recurrence in Overweight and Obese Women: Role of Prostaglandin-Aromatase Interactions
Laura W. Bowers et al.
CANCER RESEARCH (2014)
Association Between Use of β-Blockers and Prostate Cancer-Specific Survival: A Cohort Study of 3561 Prostate Cancer Patients with High-Risk or Metastatic Disease
Helene Hartvedt Grytli et al.
EUROPEAN UROLOGY (2014)
Low-Dose Aspirin Use After Diagnosis of Colorectal Cancer Does Not Increase Survival: A Case-Control Analysis of a Population-Based Cohort
Chris R. Cardwell et al.
GASTROENTEROLOGY (2014)
Anticoagulant medication at time of needle biopsy for breast cancer in relation to risk of lymph node metastasis
Rickard Ljung et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Daily Aspirin Use and Prostate Cancer-Specific Mortality in a Large Cohort of Men with Nonmetastatic Prostate Cancer
Eric J. Jacobs et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Expression of HLA Class I Antigen, Aspirin Use, and Survival After a Diagnosis of Colon Cancer
Marlies S. Reimers et al.
JAMA INTERNAL MEDICINE (2014)
Low-dose acetylsalicylic acid use and the risk of upper gastrointestinal bleeding: A meta-analysis of randomized clinical trials and observational studies
Vera E. Valkhoff et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2013)
Aspirin and Colorectal Cancer Incidence and Mortality by CTNNB1 Expression: A Molecular Pathological Epidemiology (MPE) Study
R. Sun et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2013)
Use of aspirin post-diagnosis in a cohort of patients with colorectal cancer and its association with all-cause and colorectal cancer specific mortality
C. McCowan et al.
EUROPEAN JOURNAL OF CANCER (2013)
Low-dose Aspirin and Cancer Mortality: A Meta-analysis of Randomized Trials
Edward J. Mills et al.
AMERICAN JOURNAL OF MEDICINE (2012)
Use of Aspirin postdiagnosis improves survival for colon cancer patients
E. Bastiaannet et al.
BRITISH JOURNAL OF CANCER (2012)
Aspirin and other non-steroidal anti-inflammatory drug use and colorectal cancer survival: a cohort study
A. J. Walker et al.
BRITISH JOURNAL OF CANCER (2012)
Aspirin Use after a Prostate Cancer Diagnosis and Cancer Survival in a Prospective Cohort
Preet K. Dhillon et al.
CANCER PREVENTION RESEARCH (2012)
Metformin and the Risk of Cancer Time-related biases in observational studies
Samy Suissa et al.
DIABETES CARE (2012)
Aspirin Use and the Risk of Prostate Cancer Mortality in Men Treated With Prostatectomy or Radiotherapy
Kevin S. Choe et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials
Peter M. Rothwell et al.
LANCET (2012)
Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials
Peter M. Rothwell et al.
LANCET (2012)
Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials
Annemijn M. Algra et al.
LANCET ONCOLOGY (2012)
Aspirin Use, Tumor PIK3CA Mutation, and Colorectal-Cancer Survival
Xiaoyun Liao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
PIK3CA mutation impact on survival in breast cancer patients and in ERα, PR and ERBB2-based subgroups
Magdalena Cizkova et al.
BREAST CANCER RESEARCH (2012)
Aspirin and cancer: has aspirin been overlooked as an adjuvant therapy?
R. E. Langley et al.
BRITISH JOURNAL OF CANCER (2011)
Prediagnostic non-steroidal anti-inflammatory drug use and survival after diagnosis of colorectal cancer
Anna E. Coghill et al.
GUT (2011)
Use of antidepressants and NSAIDs in relation to mortality in long-term breast cancer survivors
Karen J. Wernli et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2011)
AACR Centennial Series: The Biology of Cancer Metastasis: Historical Perspective
James E. Talmadge et al.
CANCER RESEARCH (2010)
Aspirin and non-small cell lung cancer resections: effect on long-term survival
Eustace Fontaine et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2010)
Effect of aspirin and NSAIDs on risk and survival from colorectal cancer
Farhat V. N. Din et al.
GUT (2010)
Aspirin Intake and Survival After Breast Cancer
Michelle D. Holmes et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials
Peter M. Rothwell et al.
LANCET (2010)
Breast cancer metastasis driven by ErbB2 and 14-3-3 xi A division of labor
Yingqun Wang
CELL ADHESION & MIGRATION (2010)
A Preliminary Study on the Postoperative Survival of Patients Given Aspirin After Resection for Squamous Cell Carcinoma of the Esophagus or Adenocarcinoma of the Cardia
Jun-Feng Liu et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
Aspirin Use and Survival After Diagnosis of Colorectal Cancer
Andrew T. Chan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials
LANCET (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
Effects of Non-Selective Non-Steroidal Anti-Inflammatory Drugs on the Aggressiveness of Prostate Cancer
David C. Stock et al.
PROSTATE (2008)
American society of clinical oncology guideline: Recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer
Gary H. Lyman et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Low-dose aspirin for the prevention of venous thromboembolism in breast cancer patients treated with infusional chemotherapy after insertion of central vein catheter
Giuseppe Curigliano et al.
SUPPORTIVE CARE IN CANCER (2007)
NSAIDs and breast cancer recurrence in a prospective cohort study
Marilyn L. Kwan et al.
CANCER CAUSES & CONTROL (2007)
NSAID use and survival after breast cancer diagnosis in post-menopausal women
Cindy K. Blair et al.
BREAST CANCER RESEARCH AND TREATMENT (2007)
Cardioprotective aspirin users and their excess risk of upper gastrointestinal complications
Sonia Hernandez-Diaz et al.
BMC MEDICINE (2006)
Metastasis: a question of life or death
P Mehlen et al.
NATURE REVIEWS CANCER (2006)
Drug therapy -: Low-dose aspirin for the prevention of atherothrombosis
C Patrono et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Risk of hemorrhagic stroke with aspirin use - An update
PB Gorelick et al.
STROKE (2005)
Association between aspirin and upper gastrointestinal complications:: Systematic review of epidemiologic studies
LAG Rodríguez et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2001)
Share Paper
